{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T07:49:49Z","timestamp":1715586589613},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,1,1]],"date-time":"2011-01-01T00:00:00Z","timestamp":1293840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Reviews"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1016\/j.trre.2010.10.002","type":"journal-article","created":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T09:37:01Z","timestamp":1291196221000},"page":"21-26","source":"Crossref","is-referenced-by-count":8,"title":["Induction treatment with monoclonal antibodies for heart transplantation"],"prefix":"10.1016","volume":"25","author":[{"given":"Juan F.","family":"Delgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Vaqueriza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Violeta","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Escribano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"Ruiz-Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Renes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel A.","family":"G\u00f3mez-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Cortina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos S.","family":"de la Calzada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trre.2010.10.002_bb0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1157\/13084449","article-title":"La insuficiencia cardiaca en el a\u00f1o 2005","volume":"59","author":"Jim\u00e9nez","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.trre.2010.10.002_bb0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1157\/13091628","article-title":"Asistencia mec\u00e1nica circulatoria y trasplante card\u00edaco. Indicaciones y situaci\u00f3n en Espa\u00f1a. Insuficiencia cardiaca","volume":"6","author":"G\u00f3mez","year":"2006","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.trre.2010.10.002_bb0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(98)07493-5","article-title":"Immunosuppressive strategies in transplantation","volume":"353","author":"Denton","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2010.10.002_bb0020","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.healun.2004.01.002","article-title":"To induce or not to induce: do patients at greatest risk for fatal rejection benefit from cytolytic induction therapy?","volume":"24","author":"Higgins","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0025","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.healun.2007.01.002","article-title":"Induction therapy in heart transplantation: is there a role?","volume":"26","author":"Uber","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0030","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1161\/01.CIR.0000149745.83186.89","article-title":"Drug therapy in the heart transplant recipient: part I. Cardiac rejection and immunosuppressive drugs","volume":"110","author":"Lindenfeld","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2010.10.002_bb0035","doi-asserted-by":"crossref","first-page":"333","DOI":"10.7182\/prtr.19.4.tv7686631n622273","article-title":"Induction immunosuppression for orthotopic heart transplantation: a review","volume":"19","author":"Ensor","year":"2009","journal-title":"Prog Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0040","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.healun.2005.05.018","article-title":"Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult heart transplant report 2005","volume":"24","author":"Taylor","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0045","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM200003023420902","article-title":"Prevention of rejection in cardiac transplantation in blockade of interleukin-2 receptor with monoclonal antibody","volume":"342","author":"Beniaminovitz","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2010.10.002_bb0050","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1056\/NEJMoa032953","article-title":"Daclizumab to prevent rejection after cardiac transplantation","volume":"352","author":"Hershberger","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2010.10.002_bb0055","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.transproceed.2004.12.135","article-title":"Daclizumab is associated with decreased rejection and no increased mortality in cardiac transplant patients receiving MMF, cyclosporine, and corticosteroids","volume":"37","author":"Kobashigawa","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2010.10.002_bb0060","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.healun.2004.08.003","article-title":"Induction therapy with basiliximab allows delayed initiation of cyclosporine and preserves renal function after cardiac transplantation","volume":"24","author":"Rosenberg","year":"2005","journal-title":"J Heart and lung transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0065","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.healun.2004.09.010","article-title":"A multicenter, prospective, randomized, double-blind trial of basiliximab in heart transplantation","volume":"24","author":"Mehra","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0070","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1510\/icvts.2004.105262","article-title":"Induction immunosuppression after heart transplantation: monoclonal vs. polyclonal antithymoglobulins. Is there a difference?","volume":"4","author":"Haddad","year":"2005","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.trre.2010.10.002_bb0075","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1056\/NEJM198905253202117","article-title":"Systemic reaction to the anti\u2013T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma","volume":"320","author":"Chatenoud","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trre.2010.10.002_bb0080","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2010.10.002_bb0085","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.transproceed.2004.04.070","article-title":"Basiliximab-chimeric anti\u2013IL2-R monoclonal antibody in pediatric liver transplantation. Comparative study","volume":"36","author":"Gibelli","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2010.10.002_bb0090","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/lt.20144","article-title":"Interleukin-2 receptor antibody (basiliximab) for immunosuppressive induction therapy after liver transplantation: a protocol with early elimination steroids and reduction of tacrolimus dosage","volume":"10","author":"Liu","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.trre.2010.10.002_bb0095","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/01.TP.0000109643.32659.C4","article-title":"Interleukin 2 receptor antagonist for renal transplantation recipients: a meta-analysis of randomized trials","volume":"77","author":"Webster","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0100","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0140-6736(97)09278-7","article-title":"Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 20 Intemational Study Group","volume":"350","author":"Nashan","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.trre.2010.10.002_bb0105","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00007890-200301150-00007","article-title":"Randomised double-blind study of immunoprophilaxis with basiliximab, a chimeric anti\u2013interleukin-2 receptor monoclonal antibody, in combination with mycophenolate mofetil containing triple therapy in renal transplantation","volume":"75","author":"Lawen","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0110","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000085892","article-title":"Long-term evaluation of basiliximab induction therapy in live donor kidney transplantation: a five-year prospective randomized study","volume":"25","author":"Sheashaa","year":"2005","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.trre.2010.10.002_bb0115","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.transproceed.2005.01.071","article-title":"Basiliximab (Simulect) reduces acute rejection among sensitized kidney allograft recipients","volume":"37","author":"Tan","year":"2005","journal-title":"Transplant Proc"},{"key":"10.1016\/j.trre.2010.10.002_bb0120","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1097\/01.tp.0000209924.00229.e5","article-title":"A randomized multicenter comparison of basiliximab and muromonab (OKT3) in heart transplantation: SIMCOR study","volume":"81","author":"Segovia","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0125","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1399-0012.2007.00751.x","article-title":"Influence of immunosuppressive regimens on short-term morbidity and mortality in heart transplantation","volume":"22","author":"Aguero","year":"2008","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0130","first-page":"S221","article-title":"Does acute rejection correlate with the development of transplant coronary artery disease? A multicenter study using intravascular ultrasound","volume":"14","author":"Kobashigawa","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0135","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.healun.2008.05.013","article-title":"Interleukin-2 receptor antagonists as induction therapy after heart transplantation: systematic review with meta-analysis of randomized trials","volume":"27","author":"M\u00f8ller","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0140","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.healun.2006.09.002","article-title":"Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation","volume":"25","author":"Flaman","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0145","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.healun.2007.01.006","article-title":"Basiliximab and rabbit anti-thymocyte globulin for prophylaxis of acute rejection after heart transplantation: a non-inferiority trial","volume":"26","author":"Carrier","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1034\/j.1399-0012.2000.140506.x","article-title":"A prospective economic evaluation of basiliximab (Simulect) therapy following renal transplantation","volume":"14","author":"Lorber","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0155","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1097\/00007890-200106150-00015","article-title":"Economic analysis of basiliximab in renal transplantation","volume":"71","author":"Keown","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0160","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2165\/00019053-200321110-00003","article-title":"Cost evaluation of basiliximab treatment for renal transplant patients in Japan","volume":"21","author":"Hasegawa","year":"2003","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.trre.2010.10.002_bb0165","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1432-2277.2002.tb00204.x","article-title":"The economics of basiliximab (Simulect) in preventing acute rejection in renal transplantation","volume":"15","author":"Chilcott","year":"2002","journal-title":"Transpl Int"},{"key":"10.1016\/j.trre.2010.10.002_bb0170","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/ndt\/16.5.1028","article-title":"An economic and quality-of-life assessment of basiliximab vs antithymocyte globulin immunoprophylaxis in renal transplantation","volume":"16","author":"Polsky","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0175","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.healun.2005.02.002","article-title":"Three-year results of a randomized, double-blind, controlled trial of mycophenolate mofetil versus azathioprine in cardiac transplant recipients","volume":"24","author":"Eisen","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0180","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1097\/00007890-200111270-00015","article-title":"Mycophenolate mofetil versus azathioprine in patients surviving the initial cardiac transplant hospitalization: an analysis of the Joint UNOS\/ISHLT Thoracic Registry","volume":"72","author":"Hosenpud","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate mofetil investigators","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.trre.2010.10.002_bb0190","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1111\/j.1600-6143.2006.01300.x","article-title":"Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients\u2014a large European trial","volume":"6","author":"Grimm","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0195","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/j.1600-6143.2006.01290.x","article-title":"Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report","volume":"6","author":"Kobashigawa","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0200","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.healun.2005.11.452","article-title":"Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients","volume":"25","author":"Kobashigawa","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0205","first-page":"III79","article-title":"Prophylactic OKT3 used as induction therapy for heart transplantation","volume":"80","author":"Starnes","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.trre.2010.10.002_bb0210","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1399-0012.2003.00150.x","article-title":"Basiliximab in association with tacrolimus and steroids in Caucasian cadaveric renal transplanted patients: significant decrease in early acute rejection rate and hospitalization time","volume":"18","author":"Leonard","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0215","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1034\/j.1399-0012.2003.00061.x","article-title":"Basiliximab plus low dose cyclosporine vs OKT3 for induction immunosuppression following renal transplantation","volume":"17","author":"Kode","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.trre.2010.10.002_bb0220","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.2165\/00003495-200363240-00009","article-title":"Basiliximab: a review of its use as induction therapy in renal transplantation","volume":"63","author":"Chapman","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.trre.2010.10.002_bb0225","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1517\/14740338.4.3.473","article-title":"Efficacy and safety of basiliximab in kidney transplantation","volume":"4","author":"Boggi","year":"2005","journal-title":"Expert Opin Drug Saf"}],"container-title":["Transplantation Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X10000728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955470X10000728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T17:15:48Z","timestamp":1711991748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955470X10000728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["S0955470X10000728"],"URL":"https:\/\/doi.org\/10.1016\/j.trre.2010.10.002","relation":{},"ISSN":["0955-470X"],"issn-type":[{"value":"0955-470X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}